brl 37344 Search Results


storage solution  (MedChemExpress)
92
MedChemExpress storage solution
Storage Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/storage solution/product/MedChemExpress
Average 92 stars, based on 1 article reviews
storage solution - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
brl37344 sodium salt  (Tocris)
92
Tocris brl37344 sodium salt
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Brl37344 Sodium Salt, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brl37344 sodium salt/product/Tocris
Average 92 stars, based on 1 article reviews
brl37344 sodium salt - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
brl 37344 sodium salt hydrate  (Tocris)
93
Tocris brl 37344 sodium salt hydrate
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Brl 37344 Sodium Salt Hydrate, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brl 37344 sodium salt hydrate/product/Tocris
Average 93 stars, based on 1 article reviews
brl 37344 sodium salt hydrate - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
wt tac brl 37344 group  (Santa Cruz Biotechnology)
92
Santa Cruz Biotechnology wt tac brl 37344 group
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Wt Tac Brl 37344 Group, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt tac brl 37344 group/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
wt tac brl 37344 group - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
brl-37344  (Sumitomo Dainippon)
90
Sumitomo Dainippon brl-37344
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Brl 37344, supplied by Sumitomo Dainippon, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brl-37344/product/Sumitomo Dainippon
Average 90 stars, based on 1 article reviews
brl-37344 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
brl 37344  (Broadley James Corp)
90
Broadley James Corp brl 37344
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Brl 37344, supplied by Broadley James Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brl 37344/product/Broadley James Corp
Average 90 stars, based on 1 article reviews
brl 37344 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
brl 37344  (Microm International GmbH)
90
Microm International GmbH brl 37344
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Brl 37344, supplied by Microm International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brl 37344/product/Microm International GmbH
Average 90 stars, based on 1 article reviews
brl 37344 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
brl-37344  (SmithKline Beecham Clinical)
90
SmithKline Beecham Clinical brl-37344
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Brl 37344, supplied by SmithKline Beecham Clinical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brl-37344/product/SmithKline Beecham Clinical
Average 90 stars, based on 1 article reviews
brl-37344 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
b3-adrenoceptor agonist brl37344  (Interchim Chemicals)
90
Interchim Chemicals b3-adrenoceptor agonist brl37344
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
B3 Adrenoceptor Agonist Brl37344, supplied by Interchim Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b3-adrenoceptor agonist brl37344/product/Interchim Chemicals
Average 90 stars, based on 1 article reviews
b3-adrenoceptor agonist brl37344 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
brl-37344  (CH Instruments)
90
CH Instruments brl-37344
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Brl 37344, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brl-37344/product/CH Instruments
Average 90 stars, based on 1 article reviews
brl-37344 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
phenoxyacetic acid [brl 37344, (±)-6]  (Biotrend Chemicals)
90
Biotrend Chemicals phenoxyacetic acid [brl 37344, (±)-6]
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Phenoxyacetic Acid [Brl 37344, (±) 6], supplied by Biotrend Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phenoxyacetic acid [brl 37344, (±)-6]/product/Biotrend Chemicals
Average 90 stars, based on 1 article reviews
phenoxyacetic acid [brl 37344, (±)-6] - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
brl 37344  (Bristol Myers)
90
Bristol Myers brl 37344
β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM <t>BRL37344</t> (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
Brl 37344, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brl 37344/product/Bristol Myers
Average 90 stars, based on 1 article reviews
brl 37344 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM BRL37344 (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).

Journal: Frontiers in Pharmacology

Article Title: Salmeterol, a β2 Adrenergic Agonist, Promotes Adult Hippocampal Neurogenesis in a Region-Specific Manner

doi: 10.3389/fphar.2019.01000

Figure Lengend Snippet: β 2 -AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2 + /nestin − cells are indicated (arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β 2 -AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP + (D) and NG-2 + (E) cells. (F) Effect of 3 nM SAL in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM BRL37344 (BRL) on neuronal differentiation of ahNPCs derived from β 2 -AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. ** p < 0.01, *** p < 0.001 vs. vehicle-treated cells; ### p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).

Article Snippet: The following drugs were utilized: L-(-)-norepinephrine-(+)-bitartrate salt monohydrate (NE) purchased from Sigma–Aldrich (Milan, Italy), salmeterol xinafoate, formoterol hemifumarate, ICI118,551 hydrochloride, CGP20712 dihydrochloride, SR59230A hydrochloride, and BRL37344 sodium salt purchased from Tocris (Bioscience, Bristol, UK).

Techniques: Immunolabeling, Staining, Derivative Assay, Knock-Out